Metraipolis › archive › dc_ba2cef4a737b

Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a… — Europe PMC PMID:41159027

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41159027
DOI
10.3389/fimmu.2025.1667733
License (as archived)
solo-consultazione
Archived
2026-11-09T09:04:05.003Z
SHA-256 of the archived text
d4de977dd2168b5f675cc61d7b164675b9153a1c69cbe3d2579e3ce55848fbe6
Stable URL of this page
https://metraipolis.com/documento/dc_ba2cef4a737b

How to cite

Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a… — Europe PMC PMID:41159027 — Europe PMC (en), https://europepmc.org/article/MED/41159027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ba2cef4a737b (Metraipolis archive dc_ba2cef4a737b, sha256 d4de977dd2168b5f675cc61d7b164675b9153a1c69cbe3d2579e3ce55848fbe6)
BibTeX
@misc{dcba2cef4a737b,
  title = {Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a… — Europe PMC PMID:41159027},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41159027},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ba2cef4a737b; sha256 d4de977dd2168b5f675cc61d7b164675b9153a1c69cbe3d2579e3ce55848fbe6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41159027. Agents can read the archived copy with the MCP tool read_document.